News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Conference News VIVA 2020 As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice L.A. McKeown November 27, 2020
News Daily News US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends Caitlin E. Cox November 17, 2020
News Conference News AHA 2020 Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT Shelley Wood November 15, 2020
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
Presentation TCT 2020 Regulatory Viewpoints on MCS Device Approval Presenter: Meir Shinnar October 16, 2020
Presentation TCT 2020 Industry Sponsors (Supporting Innovation and Medical Device Approval) Presenter: Manuela Negoita October 15, 2020
Presentation TCT 2020 Heart Valve Collaboratory Is Next in Line Presenter: Michael Mack October 14, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Daily News In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows L.A. McKeown September 24, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News FDA, EU Clear Fitbit ECG to Detect Atrial Fibrillation Michael O'Riordan September 15, 2020
News Daily News ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency L.A. McKeown July 02, 2020